HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Byung Ho Lee Selected Research

Oral Administration

9/2020KR-39038, a Novel GRK5 Inhibitor, Attenuates Cardiac Hypertrophy and Improves Cardiac Function in Heart Failure.
3/2017A novel urotensin II receptor antagonist, KR-36996, improved cardiac function and attenuated cardiac hypertrophy in experimental heart failure.
11/2016A urotensin II receptor antagonist, KR36676, decreases vascular remodeling and inflammation in experimental pulmonary hypertension.
3/2009Melanin-concentrating hormone-1 receptor antagonism and anti-obesity effects of ethanolic extract from Morus alba leaves in diet-induced obese mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Byung Ho Lee Research Topics

Disease

10Spinal Stenosis (Stenosis, Spinal)
04/2024 - 10/2012
8Hypertrophy
09/2020 - 07/2006
7Pain (Aches)
09/2023 - 03/2013
6Neoplasms (Cancer)
11/2019 - 05/2011
6Ischemia
01/2009 - 02/2004
5Inflammation (Inflammations)
09/2018 - 05/2011
5Myocardial Infarction
03/2017 - 10/2005
4Hypoxia (Hypoxemia)
08/2021 - 03/2006
4Heart Failure
09/2020 - 07/2006
4Infarction (Infarctions)
03/2017 - 10/2005
3Infections
09/2023 - 10/2020
3Obesity
03/2022 - 03/2009
3Cardiotoxicity
03/2022 - 02/2003
3Cardiomegaly (Heart Hypertrophy)
09/2020 - 11/2016
3Autoimmune Diseases (Autoimmune Disease)
11/2019 - 04/2009
3Atherosclerosis
05/2017 - 10/2002
3Fibrosis (Cirrhosis)
03/2017 - 02/2013
3Cardiovascular Diseases (Cardiovascular Disease)
03/2017 - 01/2013
3Reperfusion Injury
04/2009 - 02/2004
3Coronary Occlusion
01/2009 - 10/2005
2Hemorrhage
10/2022 - 05/2010
2Wounds and Injuries (Trauma)
02/2022 - 07/2007
2Pathologic Constriction (Stenosis)
01/2022 - 10/2002
2Pulmonary Hypertension
03/2017 - 11/2016
2Osteoporosis
11/2014 - 03/2013
2Vascular Diseases (Vascular Disease)
07/2014 - 10/2002
2Discitis
01/2014 - 09/2012
2Critical Illness (Critically Ill)
03/2013 - 02/2012
2Bone Resorption
03/2013 - 05/2012
2Fever (Fevers)
03/2013 - 02/2012
2Body Weight (Weight, Body)
03/2009 - 07/2006
2Acidosis
03/2006 - 03/2005
2Contracture
03/2005 - 02/2004
1Spondylolisthesis
11/2023
1Tibial Fractures (Fracture, Tibial)
09/2023
1Necrosis
09/2023
1Infertility (Sterility)
01/2023
1Congenital Abnormalities (Deformity)
01/2022
1Kyphosis
01/2022
1Spinal Cord Diseases
01/2022
1Mental Disorders (Mental Disorder)
01/2021
1Lordosis
10/2020
1Sacroiliitis
02/2020
1Glaucoma
01/2020

Drug/Important Bio-Agent (IBA)

5L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
06/2007 - 02/2004
3Biomarkers (Surrogate Marker)IBA
10/2020 - 07/2006
3urotensin IIIBA
03/2017 - 11/2016
3Proteins (Proteins, Gene)FDA Link
11/2016 - 04/2009
3Messenger RNA (mRNA)IBA
08/2016 - 04/2009
3Vitamin DFDA LinkGeneric
03/2013 - 05/2012
3Adenosine Triphosphate (ATP)IBA
03/2006 - 02/2004
3Guanidine (Guanidine Nitrate)FDA Link
03/2006 - 02/2004
2melanin-concentrating hormone receptorIBA
03/2022 - 03/2009
2Ether (Diethyl Ether)IBA
03/2022 - 01/2020
2ElementsIBA
01/2022 - 04/2009
2Angiotensin IIIBA
09/2020 - 08/2013
2G-Protein-Coupled Receptor Kinase 5IBA
09/2020 - 11/2016
2Phosphotransferases (Kinase)IBA
09/2018 - 11/2010
2KR-36996IBA
05/2017 - 03/2017
2benzothiopheneIBA
03/2017 - 03/2006
2Therapeutic UsesIBA
03/2017 - 11/2014
2CytokinesIBA
10/2014 - 02/2013
2rho-Associated KinasesIBA
08/2013 - 01/2013
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
05/2013 - 02/2012
2AntipyreticsIBA
03/2013 - 02/2012
2Sodium-Hydrogen ExchangersIBA
07/2007 - 10/2005
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
06/2007 - 10/2005
2Troponin IIBA
06/2007 - 10/2005
2N- (4- cyano- benzo(b)thiophene- 2- carbonyl)guanidineIBA
06/2007 - 03/2006
2IsoenzymesIBA
06/2007 - 10/2005
2BenzopyransIBA
07/2006 - 02/2004
2Phosphocreatine (Neoton)IBA
03/2006 - 03/2005
2Protein Isoforms (Isoforms)IBA
03/2006 - 03/2005
2GlycogenIBA
03/2006 - 03/2005
2(5- (2- methoxy- 5- chloro- 5- phenyl)furan- 2- ylcarbonyl)guanidineIBA
10/2005 - 03/2005
1MetalsIBA
09/2023
1Sex AttractantsIBA
01/2023
1Tranexamic Acid (AMCA)FDA Link
10/2022
1Appetite Depressants (Anorectics)IBA
03/2022
1KR 31831IBA
02/2022
1Mitogen-Activated Protein KinasesIBA
08/2021
1Oxygen (Dioxygen)IBA
08/2021
1Deferoxamine (Desferal)FDA LinkGeneric
08/2021
1ORALIT (ORS)IBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
10/2020

Therapy/Procedure

6Decompression
01/2022 - 07/2014
6Therapeutics
05/2017 - 05/2010
4Oral Administration
09/2020 - 03/2009
3Pedicle Screws
11/2023 - 03/2016
2Analgesia
05/2016 - 05/2013
2Curettage
01/2014 - 09/2012
1Bone Screws
04/2024
1Operative Surgical Procedures
01/2022
1Laminoplasty
01/2022
1Antibiotic Prophylaxis
01/2021
1Minimally Invasive Surgical Procedures
10/2020
1Ligation
09/2020
1Arthrodesis
02/2020
1Early Ambulation
02/2020
1Debridement
02/2020